Oriental Aromatics Ltd

- Management indicated they are already active in the RFQ (Request for Quotation) cycles for H1 FY2026. - Demand visibility across all areas of operations is described as encouraging. - The company expects strong order volumes for the upcoming half-year despite tight pricing. - There was no specific quantitative figure mentioned about the current or expected order book or pending orders. - The focus remains on driving growth through volume and maintaining market share in a competitive environment.

- No mention of any current or future fundraising through debt or equity during the call. - The company highlighted a healthy and conservative balance sheet with a net debt-to-equity ratio of 0.6x as of 30 September 2025. - Management emphasized focusing on growth through volume, process improvements, and margin restoration rather than external fundraising. - No indications or statements were made about plans to raise additional capital via debt or equity in the near future.

- The company is currently ramping up its Mahad Greenfield plant, with phase one capacity of 250 metric tons annually; this plant is in the ramp-up phase causing some EBITDA pressure but is expected to normalize in upcoming quarters. - There is no explicit mention of new or future capex plans in the transcript beyond the ongoing ramp-up and utilization improvements. - The company is focusing on process re-engineering and yield optimization internally to improve costs and margins. - Strategic raw material stocking has been increased, including camphor and fragrance raw materials, indicating inventory investment but no new capital projects specified. - The hydrogenation plant at Baroda, a brownfield project, is fully commissioned and operating, with potential for future capacity expansions hinted but no detailed capex plans disclosed. - Management is investing in business development and product launches in the B2C camphor space through brands like 3pine and Saraswati.

- Company achieved record quarterly sales with 20% growth in sales value over Q1 and 15% year-on-year. - Production grew 26% sequentially and 10% year-on-year; sales volume rose 30% quarter-on-quarter and 21% year-on-year. - Demand visibility across all operations remains encouraging with active RFQ cycles for H1 2026 showing strong outlook despite tight pricing. - Management focused on driving growth through volume leadership and market penetration in a soft price environment. - Strategic ramp-up of Mahad plant expected to normalize the current 1.5-2% EBITDA drag, improving profitability. - Priorities include volume growth, cost optimization through process re-engineering, and margin restoration to targeted 8%-10% range. - Trading business continues to grow well, expanding product offerings and quantity leverage. - New product launches and expansion in FMCG/B2C (camphor) segment being considered to boost future growth.

- Management expects growth driven by volume increase and market share gains across divisions, as highlighted by record quarterly sales and 21% volume growth year-on-year. - Margin improvement anticipated as the Mahad plant stabilizes, currently causing a 1.5%-2% EBITDA drag but expected to normalize in coming quarters. - Cost optimization through process re-engineering and yield improvement programs underway to support margin restoration to targeted 8%-10% EBITDA range. - Pricing environment remains challenging due to global buyer's market and competitive pressure from Chinese imports, but strategic raw material stocking and alignment with market prices aim to sustain volumes. - Demand visibility is encouraging with participation in upcoming RFQ cycles for H1 FY2026 indicating strong order pipeline. - Trading division growing steadily, adding incremental revenue and operational leverage. - Financial discipline maintained with net debt-to-equity at 0.6x and positive cash profit of Rs. 16.7 crore for H1 FY2026. Overall, improvement in earnings and EPS hinges on Mahad plant ramp-up, cost efficiencies, and stable pricing.